MMNFQ (MedMen Enterprises) Retained Earnings: $-941.1 Mil (As of Mar. 2023)


What is MedMen Enterprises Retained Earnings?

MedMen Enterprises MMNFQ -90.00% Retained Earnings is $-941.1 Mil as of Mar. 2023.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. MedMen Enterprises's retained earnings for the quarter that ended in Mar. 2023 was $-941.1 Mil.

MedMen Enterprises's quarterly retained earnings declined from Sep. 2022 ($-897.6 Mil) to Dec. 2022 ($-913.8 Mil) and declined from Dec. 2022 ($-913.8 Mil) to Mar. 2023 ($-941.1 Mil).

MedMen Enterprises's annual retained earnings declined from Jun. 2020 ($-631.4 Mil) to Jun. 2021 ($-717.2 Mil) and declined from Jun. 2021 ($-717.2 Mil) to Jun. 2022 ($-905.4 Mil).


MedMen Enterprises  (OTCPK:MMNFQ) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


MedMen Enterprises Retained Earnings Historical Data

* Premium members only.

The historical data trend for MedMen Enterprises's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MedMen Enterprises Retained Earnings Chart

MedMen Enterprises Annual Data
Trend Oct13 Oct14 Oct15 Oct16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22
Retained Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only -67.62 -370.38 -631.37 -717.23 -905.42

MedMen Enterprises Quarterly Data
Apr18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -820.97 -905.42 -897.61 -913.80 -941.14

MedMen Enterprises Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of $-941.1 Mil mean?
MedMen Enterprises (MMNFQ) has a Retained Earnings of $-941.1 Mil as of Mar. 2023. Retained earnings is the amount of net income not issued to shareholders. View historical data on MedMen Enterprises and its competitors.
Is MedMen Enterprises' Retained Earnings too high?
MedMen Enterprises' current Retained Earnings is $-941.1 Mil.
How does MedMen Enterprises' Retained Earnings compare to ZTS and VTRS?
MedMen Enterprises' Retained Earnings of $-941.1 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Drug Manufacturers company?
A good Retained Earnings depends on the Drug Manufacturers industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on MedMen Enterprises and its competitors. MedMen Enterprises's current Retained Earnings is $-941.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedMen Enterprises stock overvalued right now?
MedMen Enterprises (MMNFQ) has a current Retained Earnings of $-941.1 Mil. The current Retained Earnings is $-941.1 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For MedMen Enterprises (MMNFQ), the current Retained Earnings is $-941.1 Mil as of Mar. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MedMen Enterprises Business Description

Address 8740 S Sepulveda Boulevard, Suite 105, Los Angeles, CA, USA, 90045
MedMen Enterprises Inc is a American cannabis company dedicated to improving life with Cannabis for All. With operations across the United States in California, Nevada, Illinois, Arizona, Massachusetts, and New York, the company has MedMen and LuxLyte brands offering cannabis in consumer-preferred product forms for medical and recreational use. It produces and curates the consumer product assortment for retail operations in its local communities, and drives consumer loyalty with service and engaging in-store experience, combined with reward, delivery, and e-commerce programs.